Herzog RW - Search Results

1

Systemic protein delivery by muscle-gene transfer is limited by a local immune response.

Wang L, Dobrzynski E, Schlachterman A, Cao O, Herzog RW. Wang L, et al. Among authors: herzog rw. Blood. 2005 Jun 1;105(11):4226-34. doi: 10.1182/blood-2004-03-0848. Epub 2005 Feb 15. Blood. 2005. PMID: 15713796 Free PMC article.

2

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.

Herzog RW, Hagstrom JN, Kung SH, Tai SJ, Wilson JM, Fisher KJ, High KA. Herzog RW, et al. Proc Natl Acad Sci U S A. 1997 May 27;94(11):5804-9. doi: 10.1073/pnas.94.11.5804. Proc Natl Acad Sci U S A. 1997. PMID: 9159155 Free PMC article.

3

Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver.

Nakai H, Herzog RW, Hagstrom JN, Walter J, Kung SH, Yang EY, Tai SJ, Iwaki Y, Kurtzman GJ, Fisher KJ, Colosi P, Couto LB, High KA. Nakai H, et al. Among authors: herzog rw. Blood. 1998 Jun 15;91(12):4600-7. Blood. 1998. PMID: 9616156 Free article.

4

Problems and prospects in gene therapy for hemophilia.

Herzog RW, High KA. Herzog RW, et al. Curr Opin Hematol. 1998 Sep;5(5):321-6. doi: 10.1097/00062752-199809000-00003. Curr Opin Hematol. 1998. PMID: 9776210 Review.

5

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector.

Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA. Herzog RW, et al. Nat Med. 1999 Jan;5(1):56-63. doi: 10.1038/4743. Nat Med. 1999. PMID: 9883840

6

Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter.

Hagstrom JN, Couto LB, Scallan C, Burton M, McCleland ML, Fields PA, Arruda VR, Herzog RW, High KA. Hagstrom JN, et al. Among authors: herzog rw. Blood. 2000 Apr 15;95(8):2536-42. Blood. 2000. PMID: 10753832 Free article.

7

Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX.

Fields PA, Kowalczyk DW, Arruda VR, Armstrong E, McCleland ML, Hagstrom JN, Pasi KJ, Ertl HC, Herzog RW, High KA. Fields PA, et al. Among authors: herzog rw. Mol Ther. 2000 Mar;1(3):225-35. doi: 10.1006/mthe.2000.0032. Mol Ther. 2000. PMID: 10933938 Free article.

8

Posttranslational modifications of recombinant myotube-synthesized human factor IX.

Arruda VR, Hagstrom JN, Deitch J, Heiman-Patterson T, Camire RM, Chu K, Fields PA, Herzog RW, Couto LB, Larson PJ, High KA. Arruda VR, et al. Among authors: herzog rw. Blood. 2001 Jan 1;97(1):130-8. doi: 10.1182/blood.v97.1.130. Blood. 2001. PMID: 11133752 Free article.

9

Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation.

Herzog RW, Mount JD, Arruda VR, High KA, Lothrop CD Jr. Herzog RW, et al. Mol Ther. 2001 Sep;4(3):192-200. doi: 10.1006/mthe.2001.0442. Mol Ther. 2001. PMID: 11545609 Free article.

10

Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.

Fields PA, Arruda VR, Armstrong E, Chu K, Mingozzi F, Hagstrom JN, Herzog RW, High KA. Fields PA, et al. Among authors: herzog rw. Mol Ther. 2001 Sep;4(3):201-10. doi: 10.1006/mthe.2001.0441. Mol Ther. 2001. PMID: 11545610 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters